Development of MRF for Characterization of Brain Tumors After Radiotherapy
Recruiting
N/A
Interventional Study
Brain Tumor
Brain Necrosis
Brain Metastases
Glioma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 90 (estimated)
- Sponsor
- Case Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to discover the potential convenience and ease of using a Magnetic Resonance Imaging (MRI) technique, named Magnetic Resonance Fingerprinting (or MRF), to achieve high-quality images within a short scan time of 5 min for viewing the entire brain. This is an advanced quantitative assessment of brain tissues. This method is being applied with IVIM MRI to be able to tell …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria for Healthy Participants:
* Ages 18 - 60
* No history of cerebrovascular disease
* No cognitive impairments
* Able to provide informed consent
Inclusion Criteria for Participants with Brain Tumors:
* Biopsy-proven cases of developed recurrent tumor or radiation necrosis, OR
* a…
Contacts